HomePIRS • NASDAQ
add
Pieris Pharmaceuticals Inc
Previous close
$16.61
Day range
$16.85 - $16.92
Year range
$6.28 - $23.19
Market cap
22.34M USD
Avg Volume
8.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.43M | -6.50% |
Net income | -3.59M | -190.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.18M | -248.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.73M | -64.04% |
Total assets | 25.05M | -71.38% |
Total liabilities | 6.35M | -86.51% |
Total equity | 18.70M | — |
Shares outstanding | 1.32M | — |
Price to book | 1.17 | — |
Return on assets | -38.29% | — |
Return on capital | -51.35% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -3.59M | -190.29% |
Cash from operations | -1.48M | 88.98% |
Cash from investing | 2.18M | 259.30% |
Cash from financing | — | — |
Net change in cash | 647.00K | -87.55% |
Free cash flow | 1.30M | 121.53% |
About
Founded
2001
Headquarters
Website
Employees
48